🔓
Sign in as a Member to unlock the full view of HR.10133. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HR.10133 · 119TH CONGRESS

Fair Prescription Pricing Act of 2026

Status
In Committee
Latest Action
2026-08-20
Sponsor
Scholten, Hillary J. (D-Michigan)
Official Source
Congress.gov
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
Unavailable
Alive
Yes

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Frequently Asked Questions

Did HR.10133 pass?
HR.10133 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.10133?
HR.10133 was sponsored by Hillary J. Scholten (D-Michigan).

Full Bill Text

⚖️ View on Congress.gov 📄 PDF (GovInfo) 🔗 Copy link
Full text not yet indexed for this bill. Check Congress.gov for the official text.
🔒 GovGreed Pro · Trading Intelligence on HR.10133 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-08-28. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]